Scott Grytdal1, Hannah Browne1,2, Nikail Collins1, Blanca Vargas3, Maria C Rodriguez-Barradas3,4, David Rimland5, David O Beenhouwer6,7, Sheldon T Brown8,9, Matthew Bidwell Goetz6,7, Cynthia Lucero-Obusan10, Mark Holodniy10, Anita Kambhampati1,11, Umesh Parashar1, Jan Vinjé1, Ben Lopman1,12, Aron J Hall1, Cristina V Cardemil1. 1. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Oak Ridge Institute for Science and Education, Tennessee. 3. Infectious Diseases Section, Michael E. DeBakey Veterans Affairs Medical Center. 4. Infectious Diseases Section, Baylor College of Medicine, Houston, Texas. 5. Atlanta Veterans Affairs Medical Center, Georgia. 6. Veterans Affairs Greater Los Angeles Healthcare System, California. 7. David Geffen School of Medicine, University of California, Los Angeles. 8. James J. Peters Veterans Affairs Medical Center. 9. Mount Sinai School of Medicine, Bronx, New York. 10. Public Health Surveillance and Research, Department of Veterans Affairs, Palo Alto, California. 11. IHRC, Inc. 12. Rollins School of Public Health, Emory University, Atlanta, Georgia.
Abstract
BACKGROUND: Norovirus is an important cause of epidemic acute gastroenteritis (AGE), yet the burden of endemic disease in adults has not been well documented. We estimated the prevalence and incidence of outpatient and community-acquired inpatient norovirus AGE at 4 Veterans Affairs Medical Centers (VAMC) (Atlanta, Georgia; Bronx, New York; Houston, Texas; and Los Angeles, California) and examined trends over 4 surveillance years. METHODS: From November 2011 to September 2015, stool specimens collected within 7 days of AGE symptom onset for clinician-requested diagnostic testing were tested for norovirus, and positive samples were genotyped. Incidence was calculated by multiplying norovirus prevalence among tested specimens by AGE-coded outpatient encounters and inpatient discharges, and dividing by the number of unique patients served. RESULTS: Of 1603 stool specimens, 6% tested were positive for norovirus; GII.4 viruses (GII.4 New Orleans [17%] and GII.4 Sydney [47%]) were the most common genotypes. Overall prevalence and outpatient and inpatient community-acquired incidence followed a seasonal pattern, with higher median rates during November-April (9.2%, 376/100 000, and 45/100 000, respectively) compared to May-October (3.0%, 131/100 000, and 13/100 000, respectively). An alternate-year pattern was also detected, with highest peak prevalence and outpatient and inpatient community-acquired norovirus incidence rates in the first and third years of surveillance (14%-25%, 349-613/100 000, and 43-46/100 000, respectively). CONCLUSIONS: This multiyear analysis of laboratory-confirmed AGE surveillance from 4 VAMCs demonstrates dynamic intra- and interannual variability in prevalence and incidence of outpatient and inpatient community-acquired norovirus in US Veterans, highlighting the burden of norovirus disease in this adult population. Published by Oxford University Press for the Infectious Diseases Society of America 2019.
BACKGROUND: Norovirus is an important cause of epidemic acute gastroenteritis (AGE), yet the burden of endemic disease in adults has not been well documented. We estimated the prevalence and incidence of outpatient and community-acquired inpatient norovirus AGE at 4 Veterans Affairs Medical Centers (VAMC) (Atlanta, Georgia; Bronx, New York; Houston, Texas; and Los Angeles, California) and examined trends over 4 surveillance years. METHODS: From November 2011 to September 2015, stool specimens collected within 7 days of AGE symptom onset for clinician-requested diagnostic testing were tested for norovirus, and positive samples were genotyped. Incidence was calculated by multiplying norovirus prevalence among tested specimens by AGE-coded outpatient encounters and inpatient discharges, and dividing by the number of unique patients served. RESULTS: Of 1603 stool specimens, 6% tested were positive for norovirus; GII.4 viruses (GII.4 New Orleans [17%] and GII.4 Sydney [47%]) were the most common genotypes. Overall prevalence and outpatient and inpatient community-acquired incidence followed a seasonal pattern, with higher median rates during November-April (9.2%, 376/100 000, and 45/100 000, respectively) compared to May-October (3.0%, 131/100 000, and 13/100 000, respectively). An alternate-year pattern was also detected, with highest peak prevalence and outpatient and inpatient community-acquired norovirus incidence rates in the first and third years of surveillance (14%-25%, 349-613/100 000, and 43-46/100 000, respectively). CONCLUSIONS: This multiyear analysis of laboratory-confirmed AGE surveillance from 4 VAMCs demonstrates dynamic intra- and interannual variability in prevalence and incidence of outpatient and inpatient community-acquired norovirus in US Veterans, highlighting the burden of norovirus disease in this adult population. Published by Oxford University Press for the Infectious Diseases Society of America 2019.
Authors: Eyal Leshem; Jacqueline E Tate; Claudia A Steiner; Aaron T Curns; Ben A Lopman; Umesh D Parashar Journal: JAMA Date: 2015-06-09 Impact factor: 56.272
Authors: Lisa Lindsay; Joanne Wolter; Ilse De Coster; Pierre Van Damme; Thomas Verstraeten Journal: BMC Infect Dis Date: 2015-10-14 Impact factor: 3.090
Authors: Aron J Hall; Ben A Lopman; Daniel C Payne; Manish M Patel; Paul A Gastañaduy; Jan Vinjé; Umesh D Parashar Journal: Emerg Infect Dis Date: 2013-08 Impact factor: 6.883
Authors: Thomas Verstraeten; Tom Cattaert; John Harris; Ben Lopman; Clarence C Tam; Germano Ferreira Journal: J Infect Dis Date: 2017-11-15 Impact factor: 5.226
Authors: Cristina V Cardemil; Neha Balachandran; Anita Kambhampati; Scott Grytdal; Rebecca M Dahl; Maria C Rodriguez-Barradas; Blanca Vargas; David O Beenhouwer; Karen V Evangelista; Vincent C Marconi; Kathryn L Meagley; Sheldon T Brown; Adrienne Perea; Cynthia Lucero-Obusan; Mark Holodniy; Hannah Browne; Rashi Gautam; Michael D Bowen; Jan Vinjé; Umesh D Parashar; Aron J Hall Journal: Clin Infect Dis Date: 2021-11-02 Impact factor: 20.999
Authors: Cristina V Cardemil; Rebecca Dahl; Mila M Prill; Jordan Cates; Sheldon Brown; Adrienne Perea; Vincent Marconi; LaSara Bell; Maria C Rodriguez-Barradas; Gilberto Rivera-Dominguez; David Beenhouwer; Aleksandra Poteshkina; Mark Holodniy; Cynthia Lucero-Obusan; Neha Balachandran; Aron J Hall; Lindsay Kim; Gayle Langley Journal: JMIR Public Health Surveill Date: 2021-01-22